Skip to main content
Atrás
GHRS logo

GH Research PLC

Calidad de datos: 100%
GHRS
NASDAQ Healthcare Biotechnology
$13.21
▼ $0.76 (-5.44%)
Cap. Mercado: 819.41M
Rango del Día
$13.12 $14.19
Rango de 52 Semanas
$7.98 $19.51
Volumen
291,900
Promedio 50D / 200D
$15.62 / $14.17
Cierre Anterior
$13.97

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Healthcare (626 pares)

Métrica Acción Mediana del Sector
P/E -17.0 0.4
P/B 2.9 2.9
ROE % -21.0 3.7
Net Margin % 3.8
Rev Growth 5Y % 10.0
D/E 0.0 0.2

Puntos Clave

Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -43.67M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-21.04%
ROIC-16.24%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
0.00
Current Ratio34.13
Interest Coverage-131.05

Valoración

P/E Ratio
-16.98
P/B Ratio2.93
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -48.26M
ROE -21.04% ROA -16.74%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -43.67M
ROIC -16.24% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.00 Current Ratio 34.13
Interest Coverage -131.05 Dividend Yield 0.00%
Valuation
P/E Ratio -16.98 P/B Ratio 2.93
P/S Ratio N/A PEG Ratio -3.01
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 819.41M Enterprise Value 573.67M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0.0 0.0 0.0 0.0 0.0
Net Income -48.26M -38.96M -35.59M -22.46M -9.20M
EPS (Diluted) -0.79 -0.75 -0.68 -0.14 -0.18
Gross Profit -335,000.0 0.0 0.0 0.0 0.0
Operating Income -60.68M -50.31M -41.22M -30.55M -15.10M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 288.23M 188.27M 226.30M 254.36M 279.92M
Total Liabilities 8.53M 9.32M 7.33M 4.55M 2.75M
Shareholders' Equity 279.70M 178.95M 218.97M 249.82M 277.18M
Total Debt 512,000.0 624,000.0 974,000.0 0.0 0.0
Cash & Equivalents 246.25M 100.79M 78.42M 165.96M 276.78M
Current Assets 285.98M 154.23M 164.09M 168.54M 279.84M
Current Liabilities 8.38M 8.95M 6.70M 4.55M 2.75M